Twist Bioscience Corporation ( TWST) - Key Metrics
TWST Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | $1.90 | -$0.56 | $0.02 | -$0.14 |
| 2026Q2 | $1.79 | -$0.71 | -$0.28 | -$0.41 |
| 2026Q1 | $1.70 | -$0.50 | -$0.41 | -$0.57 |
| 2025Q4 | $1.64 | -$0.45 | -$0.20 | -$0.40 |
| 2025Q3 | $1.60 | $0.34 | -$0.02 | -$0.18 |
TWST Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | 0% | -45.93 |
| 2026Q2 | 0% | -16.73 |
| 2026Q1 | 0% | -15.86 |
| 2025Q4 | 0% | -15.63 |
| 2025Q3 | 0% | 27.05 |
TWST
Price: $124.72
52 week price:
Earnings Per Share: -2.23 USD
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 1.1 million
Market Capitalization: 7.8 billion